Then, we highlight the most recent progress in targeting TGFβ signaling to enhance chemotherapy efficacy by normalizing the ECM, modulating the tumor vasculature, suppressing EMT, and eliminating CSCs. The gene discussed is TGFB1; the disease is neoplasm.